1. Home
  2. TOUR vs ACRS Comparison

TOUR vs ACRS Comparison

Compare TOUR & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOUR
  • ACRS
  • Stock Information
  • Founded
  • TOUR 2006
  • ACRS 2012
  • Country
  • TOUR China
  • ACRS United States
  • Employees
  • TOUR N/A
  • ACRS N/A
  • Industry
  • TOUR Transportation Services
  • ACRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOUR Consumer Discretionary
  • ACRS Health Care
  • Exchange
  • TOUR Nasdaq
  • ACRS Nasdaq
  • Market Cap
  • TOUR 122.8M
  • ACRS 132.0M
  • IPO Year
  • TOUR 2014
  • ACRS 2015
  • Fundamental
  • Price
  • TOUR $1.08
  • ACRS $3.06
  • Analyst Decision
  • TOUR
  • ACRS Strong Buy
  • Analyst Count
  • TOUR 0
  • ACRS 5
  • Target Price
  • TOUR N/A
  • ACRS $8.75
  • AVG Volume (30 Days)
  • TOUR 226.2K
  • ACRS 4.2M
  • Earning Date
  • TOUR 12-05-2024
  • ACRS 11-06-2024
  • Dividend Yield
  • TOUR N/A
  • ACRS N/A
  • EPS Growth
  • TOUR N/A
  • ACRS N/A
  • EPS
  • TOUR N/A
  • ACRS N/A
  • Revenue
  • TOUR $72,825,718.00
  • ACRS $27,079,000.00
  • Revenue This Year
  • TOUR $20.26
  • ACRS N/A
  • Revenue Next Year
  • TOUR $15.73
  • ACRS N/A
  • P/E Ratio
  • TOUR N/A
  • ACRS N/A
  • Revenue Growth
  • TOUR 87.48
  • ACRS 26.35
  • 52 Week Low
  • TOUR $0.59
  • ACRS $0.80
  • 52 Week High
  • TOUR $1.76
  • ACRS $5.17
  • Technical
  • Relative Strength Index (RSI)
  • TOUR 50.83
  • ACRS 46.47
  • Support Level
  • TOUR $1.01
  • ACRS $2.91
  • Resistance Level
  • TOUR $1.15
  • ACRS $3.29
  • Average True Range (ATR)
  • TOUR 0.07
  • ACRS 0.29
  • MACD
  • TOUR -0.00
  • ACRS -0.17
  • Stochastic Oscillator
  • TOUR 57.14
  • ACRS 11.21

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. All the company's revenues are derived from within the People's Republic of China.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases. The contract research segment earns revenue from the provision of laboratory services. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777.

Share on Social Networks: